Scarica l'app Stockscreener
6.30
3.15%
-0.205
Dopo l'orario di chiusura:
6.30
Precedente Chiudi:
$6.505
Aprire:
$6.2
Volume 24 ore:
8,199
Relative Volume:
1.60
Capitalizzazione di mercato:
$7.76M
Reddito:
$186.70K
Utile/perdita netta:
$-7.33M
Rapporto P/E:
-0.7469
EPS:
-8.4345
Flusso di cassa netto:
$-2.00M
1 W Prestazione:
+8.06%
1M Prestazione:
-9.87%
6M Prestazione:
-29.53%
1 anno Prestazione:
-18.50%
Intervallo 1D:
$6.20
$6.66
Intervallo di 1 settimana:
$5.635
$6.73
Portata 52W:
$5.57
$12.05
Addex Therapeutics Ltd Adr Stock (ADXN) Company Profile
Nome
Addex Therapeutics Ltd Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare ADXN vs VRTX, REGN, ALNY, ARGX, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADXN
Addex Therapeutics Ltd Adr
|
6.30 | 8.01M | 186.70K | -7.33M | -2.00M | -8.4345 |
VRTX
Vertex Pharmaceuticals Inc
|
453.74 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
756.73 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.16 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
692.83 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
147.60 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Addex Therapeutics Ltd Adr Stock (ADXN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-31 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
Addex Therapeutics Ltd Adr Borsa (ADXN) Ultime notizie
Solidion Technology Inc. (NASDAQ:STI) Sees Significant Growth in Short Interest - Defense World
Short Interest in Raia Drogasil S.A. (OTCMKTS:RADLY) Increases By 138.8% - Defense World
SPDR SSgA Multi-Asset Real Return ETF (NYSEARCA:RLY) Short Interest Up 142.0% in February - Defense World
Short Interest in Intrum AB (publ) (OTCMKTS:ITJTY) Grows By 140.2% - Defense World
Breakwave Tanker Shipping ETF (NYSEARCA:BWET) Short Interest Update - Defense World
Addex Therapeutics (NASDAQ:ADXN) Trading 2% Higher – Here’s Why - Defense World
Addex publishes negative allosteric modulators data in Molecular Psychiatry - TipRanks
CGX Energy (CVE:OYL) Shares Up 17.2% – Should You Buy? - Defense World
FedEx Corporation $FDX Shares Purchased by Transcend Capital Advisors LLC - Defense World
Orex Minerals (CVE:REX) Shares Down 22.8% – What’s Next? - Defense World
Paycom Software (NYSE:PAYC) Price Target Lowered to $210.00 at UBS Group - Defense World
Addex Therapeutics (ADXN) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Addex Therapeutics earnings call: Progress amidst financial challenges - MSN
Addex Therapeutics Earnings Call: Progress Amidst Financial Challenges - The Globe and Mail
Addex Therapeutics Reports Q3 2025 Financial Results - The Globe and Mail
Earnings call transcript: Addex Therapeutics Q3 2025 sees stock dip post-earnings By Investing.com - Investing.com South Africa
Earnings call transcript: Addex Therapeutics Q3 2025 sees stock dip post-earnings - Investing.com India
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Total debt per share of Addex Therapeutics Ltd Sponsored ADR – MUN:APE1 - TradingView
Addex Therapeutics (NASDAQ:ADXN) Stock Price Down 5.5% – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Monday's After-Market Session - Sahm
How geopolitical risks impact Addex Therapeutics Ltd (APE) stockShare Buyback & Consistent Growth Equity Picks - newser.com
[F-3] Addex Therapeutics Ltd. Foreign Issuer Shelf Registration | ADXN SEC FilingForm F-3 - Stock Titan
Why Addex Therapeutics Ltd (APE) stock stays on buy listsJuly 2025 Weekly Recap & Weekly High Potential Alerts - newser.com
Short Interest in Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) Grows By 61.0% - Defense World
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) Short Interest Down 91.1% in September - Defense World
Revenue per share of Addex Therapeutics Ltd Sponsored ADR – BER:APE1 - TradingView
Addex Therapeutics Earnings Call: Strategic Gains Amid Challenges - MSN
Addex Therapeutics (NASDAQ:ADXN) Shares Up 5.6% – Here’s What Happened - Defense World
Addex Therapeutics’ (ADXN) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - Defense World
Addex Therapeutics Reports Significant Loss Amid Financial Challenges - The Globe and Mail
Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) Sees Significant Increase in Short Interest - Defense World
Addex Therapeutics H1 2025 Earnings Call Transcript - MarketBeat
Addex Therapeutics (NASDAQ:ADXN) Shares Down 6.5% – What’s Next? - Defense World
Is This The Best Time To Buy iSpecimen Inc (NASDAQ: ISPC) Stock? - stocksregister.com
Addex Therapeutics Ltd Stock Price Today | NASDAQ: ADXN Live - Investing.com
European Equities See Growth In US ADR Market - Finimize
Addex Therapeutics Ltd_December 31, 2024 - SEC.gov
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? - Nasdaq
Addex Stock Soars on Crucial Update From Indivior Research Deal - Yahoo Finance
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? - Nasdaq
Is Alcon (ALC) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Addex Therapeutics (ADXN) Stock Forecast and Price Target 2026 - MarketBeat
Earnings call: Addex Therapeutics reports on collaborations and financials - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
60 Degrees Pharmaceuticals (SXTP) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
What is the current Price Target and Forecast for Addex Therapeutics (ADXN) - Zacks Investment Research
Addex Therapeutics earnings matched, revenue topped estimates - Investing.com India
Where to Find Earnings Call Transcripts - MarketBeat
Addex Therapeutics Ltd Adr Azioni (ADXN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.04%
0.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):